Literature DB >> 22139444

microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

Huaijun Zhou1, Xiaofeng Xu, Qingying Xun, Dongqi Yu, Jingxian Ling, Feifei Guo, Yuhua Yan, Jiayu Shi, Yali Hu.   

Abstract

It is well known that microRNAs (miRNAs) play important roles in cancer development by targeting oncogenes or tumor-suppressor genes. However, little is known regarding the mechanisms of miR-30c action in endometrial cancer. In this study, we aimed to determine whether miR-30c targets metastasis-associated gene-1 (MTA1) and acts as a tumor suppressor in endometrial cancer cell lines Ishikawa (estrogen receptor-positive, ER+) and HEC-1-B (ER-) by down-regulating MTA1. As a result, in both Ishikawa and HEC-1-B cells, real-time PCR demonstrated that overexpression of miR-30c led to the down-regulation of MTA1 mRNA (P<0.05), while Western blotting confirmed the reduced expression levels of MTA1 protein (P<0.01). A dual-luciferase reporter assay demonstrated that miR-30c was directly bound to the 3'-untranslated regions of MTA1. Then we studied the biological mechanisms of endometrial cancer cells transfected with the Pre-miR-30c plasmid. MTT assay and growth curves revealed that miR-30c inhibits both Ishikawa and HEC-1-B cell proliferation. However, we did not see obvious differences in rates of apoptosis between miR-30c-overexpressing and the negative control cells. Then using wound-healing and Matrigel invasion assays, we found that the migratory and invasive abilities of cells transfected with the Pre-miR-30c plasmid were significantly suppressed compared with the control cells (P<0.01). Overall, our study, for the first time, showed that MTA1 is negatively regulated by miR-30c and that overexpression of miR-30c inhibits the proliferative, migratory and invasive abilities of endometrial cancer cells. These results suggest that miR-30c acts as a tumor suppressor and negatively regulates endometrial cancer cells by targeting MTA1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139444     DOI: 10.3892/or.2011.1574

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  29 in total

1.  Recent findings on epigenetic gene abnormalities involved in uterine cancer.

Authors:  Megumi Yanokura; Kouji Banno; Yusuke Kobayashi; Hiroyuki Nomura; Shigenori Hayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2017-09-20

2.  MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.

Authors:  Xiao-hui Ling; Zhao-dong Han; Dan Xia; Hui-chan He; Fu-neng Jiang; Zhuo-yuan Lin; Xin Fu; Ye-han Deng; Qi-shan Dai; Chao Cai; Jia-hong Chen; Yu-xiang Liang; Wei-de Zhong; Chin-lee Wu
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

3.  Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.

Authors:  Jun Zhang; Xilong Wang; Yangyun Wang; Ruixian Peng; Zhiyuan Lin; Yang Wang; Bo Hu; Jifeng Wang; Guowei Shi
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

4.  miR-30c negatively regulates the migration and invasion by targeting the immediate early response protein 2 in SMMC-7721 and HepG2 cells.

Authors:  Wenjuan Wu; Xizhi Zhang; Yuexia Liao; Weicheng Zhang; Haichao Cheng; Zijing Deng; Jingyuan Shen; Qing Yuan; Yu Zhang; Weigan Shen
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 5.  Post-transcriptional regulation of MTA family by microRNAs in the context of cancer.

Authors:  Yun Zhang; Xiao-Fan Wang
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

6.  Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury.

Authors:  Yan-Fang Zou; Dan Wen; Qian Zhao; Ping-Yan Shen; Hao Shi; Qiang Zhao; Yong-Xi Chen; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

Review 7.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

Review 8.  MicroRNAs in endometrial cancer.

Authors:  Kouji Banno; Megumi Yanokura; Iori Kisu; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2013-02-05       Impact factor: 3.402

Review 9.  miRNAs as biomarkers in prostate cancer.

Authors:  Irene Casanova-Salas; José Rubio-Briones; Antonio Fernández-Serra; Jose Antonio López-Guerrero
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

10.  Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.

Authors:  Christiane Katzerke; Vikas Madan; Dennis Gerloff; Daniela Bräuer-Hartmann; Jens-Uwe Hartmann; Alexander Arthur Wurm; Carsten Müller-Tidow; Susanne Schnittger; Daniel G Tenen; Dietger Niederwieser; Gerhard Behre
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.